China Biologic Products Holdings, Inc., a fully integrated plasma-based biopharmaceutical company in China, announced that its board has received an unsolicited, preliminary non-binding proposal letter from CCRE Holdings Limited, a wholly owned subsidiary of CITIC Capital Holdings Limited. CITIC proposes to acquire all of the outstanding shares of the company not already owned by CITIC for $110 in…